View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Sten Gustafsson

Good start but sales commission still too high

Solid start in Q1. Higher sales commissions weigh down on EBIT in '25e-'26e. Fair value revised down to SEK 8-15 (9-16).

Nebag AG: 1 director

A director at Nebag AG bought 6,000 shares at 7.300CHF and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...

 PRESS RELEASE

Indberetning af ledende medarbejderes transaktioner

Indberetning af ledende medarbejderes transaktioner MEDDELELSE NR. 265 Indberetning af ledende medarbejderes transaktioner ChemoMetec A/S har i henhold til artikel 19 i forordning (EU) nr. 596/2014 modtaget nedenstående indberetning om transaktioner i ChemoMetec A/S aktier udført af personer med ledelsesansvar og/eller personer, der er nært knyttet til dem. Se indberetning af bestyrelsesmedlem Peter Reichs transaktioner i vedhæftede pdf-dokument. Yderligere oplysninger kan fås ved henvendelse til: Niels Høy Nielsen, CFO Telefon: (+45) 25 51 87 24         Om ChemoMetec A/S C...

 PRESS RELEASE

Notification of managers’ transactions

Notification of managers’ transactions ANNOUNCEMENT NO. 265 Notification of managers’ transactions ChemoMetec A/S has received the enclosed notification pursuant to Article 19 of EU Regulation no. 596/2014 of transactions related to shares in ChemoMetec A/S made by persons discharging managerial responsibilities in ChemoMetec A/S and/or persons closely associated with them. See the transactions of member of the Board of Directors Peter Reich in the attached PDF document. For further information, please contact: Niels Høy Nielsen, CFOTelephone (+45) 2551 8724 About ChemoMetec...

Qatar National Navigation & Transport Co: 1 director

A director at Qatar National Navigation & Transport Co sold 768,159 shares at 0.000QAR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over ...

 PRESS RELEASE

Disc Medicine Announces Multiple Presentations Across Portfolio at the...

Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress Additional analyses of data from AURORA, as well as the full adult data set from BEACONUpdated data from the ongoing Phase 1b study of DISC-0974 in myelofibrosis (MF) patients with anemia, including a larger data set and longer follow-up, to be shared in a posterPreliminary data on safety and pharmacodynamic activity from initial single-ascending dose (SAD) cohorts of phase 1 study of DISC-3405 in healthy volunteers WATERTOWN, Mass., May 14, 2024 (GLOBE NEWSWIRE) -...

Luis Arredondo
  • Luis Arredondo

ACS: 1Q’24 RESULTS (ANÁLISIS BANCO SABADELL)

1Q'24 vs. 1Q'23 Results Sales: € 8.706 Bn (+7.3% vs. +4.0% BS(e) and +5.4% consensus); EBITDA: € 461.0 M (-0.2% vs. +0.7% BS(e) and +1.7% consensus); EBIT: € 327.0 M (-0.3% vs. +0.1% BS(e) and +1.5% consensus); Net Profit: € 177.0 M (+8.6% vs. -4.2% BS(e) and +1.2% consensus);

Vimian Group AB: 1 director

A director at Vimian Group AB bought 10,000 shares at 34.330SEK and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

Sandvik AB: 1 director

A director at Sandvik AB bought 32,000 shares at 231.800SEK and the significance rating of the trade was 88/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...

Qatar German Co For Medical Devices: 1 director

A director at Qatar German Co For Medical Devices sold 240,000 shares at 0.000QAR and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the la...

Moody's Ratings upgrades ratings in Canterbury Finance No. 2 PLC

Moody's Ratings (Moody's), has today upgraded the ratings of four notes in Canterbury Finance No. 2 PLC. The rating action reflects increased levels of credit enhancement for the affected notes and better than expected collateral performance. Moody's affirmed the ratings of the notes that had suff...

Aixtron AG: 1 director

A director at Aixtron AG bought 4,000 shares at 22.000EUR and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

Mobico Group : 1 director

A director at Mobico Group maiden bought 40,000 shares at 64p and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...

United Development Co: 1 director

A director at United Development Co bought 398,847 shares at 0.000QAR and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...

National Vision Holdings Inc: 2 directors

Two Directors at National Vision Holdings Inc bought 54,000 shares at between 14.447USD and 14.960USD. The significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's dire...

Andy Hanson
  • Andy Hanson

Audio Note: Norcros - Capital Markets Day – taking the next step

In this audio note, Zeus’ Andy Hanson summarises the investment case for Norcros. Norcros recently hosted a Capital Markets Day (CMD) signalling a change in how the business communicates with the market.

 PRESS RELEASE

Middlefield Canadian Income PCC: Net Asset Value(s)

Middlefield Canadian Income PCC: Net Asset Value(s) Middlefield Canadian Income PCC Net Asset Value Middlefield Canadian Income PCC Middlefield Canadian Income - GBP PC (a protected cell company incorporated in Jersey with registration number 93546)Legal Entity Identifier: 2138007ENW3JEJXC8658 Net Asset Value As at the close of business on 13 May 2024 the estimated unaudited Net Asset Value per share was 125.28 pence (including accrued income). Investments in the Company's portfolio have been valued on a bid price basis. Enquiries: JTC Fund Solutions (Jersey) Limited01534 700 000 ...

President Automobile Industries Public Company Ltd: 1 director

A director at President Automobile Industries Public Company Ltd bought 6,000,000 shares at 1.700THB and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's di...

 PRESS RELEASE

Affimed Announces Acceptance of an Abstract on Preclinical Data of its...

Affimed Announces Acceptance of an Abstract on Preclinical Data of its Innate Cell Engager AFM28 at the European Hematology Association 2024 Congress Treatment with AFM28 innate cell engager (ICE®), designed to target CD123-positive cancer cells in patients with acute myeloid leukemia (AML), led to dose-dependent tumor growth control in a validated in vivo mouse modelAFM28 led to an effective reduction of CD123-expressing AML patient-derived leukemic blasts and stem cells in a newly engineered ex vivo bone marrow niche model MANNHEIM, Germany, May 14, 2024 (GLOBE NEWSWIRE) -- Affimed N...

 PRESS RELEASE

Indberetning af ledende medarbejderes transaktioner

Indberetning af ledende medarbejderes transaktioner MEDDELELSE NR. 264   Indberetning af ledende medarbejderes transaktioner ChemoMetec A/S har i henhold til artikel 19 i forordning (EU) nr. 596/2014 modtaget nedenstående indberetning om transaktioner i ChemoMetec A/S aktier udført af personer med ledelsesansvar og/eller personer, der er nært knyttet til dem. Se indberetning af næstformand for ChemoMetecs bestyrelse Martin Glensbjergs transaktioner i vedhæftede pdf-dokument. Yderligere oplysninger kan fås ved henvendelse til: Niels Høy Nielsen, CFO T...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch